NOVEL(SZ:002014)2019-10-24 16:00Financial Performance - Operating revenue for the reporting period was CNY 705,268,302.24, an increase of 15.22% year-on-year [7]. - Net profit attributable to shareholders was CNY 78,789,628.59, representing a year-on-year increase of 36.30% [7]. - Basic earnings per share were CNY 0.16, up 45.45% compared to the same period last year [7]. - Total operating revenue for Q3 2019 was CNY 705,268,302.24, an increase of 15.2% compared to CNY 612,105,578.22 in the same period last year [32]. - Net profit for Q3 2019 reached CNY 80,332,033.18, representing a 35.0% increase from CNY 59,476,134.75 in Q3 2018 [33]. - The net profit for the third quarter of 2019 was CNY 139,111,383.49, an increase of 6.0% compared to CNY 130,432,220.46 in the same period last year [44]. - Operating profit reached CNY 162,738,568.62, up from CNY 152,391,096.72, reflecting a growth of 5.9% year-over-year [44]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,502,305,667.66, a decrease of 1.36% compared to the end of the previous year [7]. - Total assets as of September 30, 2019, were ¥2,502,305,667.66, down from ¥2,536,881,163.02 at the end of 2018 [27]. - Total liabilities increased to ¥693,751,867.24 from ¥663,766,443.80 year-over-year [26]. - Total liabilities were CNY 465,924,973.88, an increase from CNY 434,504,317.60 in the previous quarter [30]. - The company's total equity as of September 30, 2019, was ¥1,808,553,800.42, down from ¥1,873,114,719.22 at the end of 2018 [27]. - The company’s total equity decreased to CNY 1,630,891,436.39 from CNY 1,741,296,363.01 in the previous quarter, reflecting changes in retained earnings [30]. Cash Flow - Cash flow from operating activities was CNY 75,906,856.83, a decrease of 29.64% compared to the previous year [7]. - The net cash flow from operating activities was CNY 186,265,883.27, an increase of 21.0% compared to CNY 153,829,023.04 in the same period last year [46]. - Cash and cash equivalents at the end of the period totaled CNY 566,896,548.71, compared to CNY 574,277,863.14 at the end of the previous year [47]. - The net cash flow from operating activities increased to ¥167,477,320.98, up from ¥70,172,085.81 in the previous period, representing a growth of approximately 138.5% [49]. - The net cash flow from investing activities was ¥197,485,619.83, down from ¥237,743,784.12, showing a decline of about 16.9% [49]. - The company paid CNY 177,419,606.45 in dividends and interest, an increase from CNY 155,039,448.23 in the previous year, representing a rise of 14.3% [46]. Research and Development - Research and development expenses increased by 53.56% year-on-year, reflecting higher investment in product development [15]. - The company reported a significant increase in R&D expenses, totaling CNY 27,209,142.11, up from CNY 17,528,110.43 in Q3 2018, reflecting a focus on innovation [32]. - Research and development expenses increased to ¥16,322,557.56, up 39.9% from ¥11,663,321.78 in the previous period [36]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 19,536 [11]. - The company repurchased a total of 10,806,835 shares, accounting for approximately 2.15% of the total share capital, with a total payment of ¥75,014,057.36 [16]. - In the third quarter of 2019, the company repurchased 2,536,750 shares, representing about 0.50% of the total share capital, for a total amount of ¥17,249,164.00 [16].